April 7, 2015 – NEW YORK — World-renowned stem cell researcher, founder and chief medical officer of Blue Horizon International (BHI) and Blue Horizon Stem Cells (BHSC), Brian Mehling, MD, is one of the four international speakers at the Slovak Geriatrics Congress on April 15-17, 2015 in Strbske Pleso, Slovakia.
Dr Mehling will deliver his presentation “Safety Study of Intravenously Administered Human Cord Blood Stem Cells in the Treatment of Symptoms Related to Chronic Inflammation”
More than 300 doctors and medical professionals hailing from various countries will convene at the 14th annual meeting, which is taking place under the patronage of the president of the Slovak Republic, Hon. Andrej Kiska.
“Stem cell treatments are, without a doubt, the future of medicine and we believe their role in treatments will become the preferred substitutes for many surgical, pharmacological, and rehabilitative medical services,” Dr. Mehling stated. “It is important that doctors and medical profesionals working in the field of geriatricmedicine are educated on what direction the world will take in regard to stem cell research and therapies. The possibilities in stem cell research and regenerative medicine are endless. It is crucial for physicians to be aware of the therapies available for patients with different chronic conditions, disorders, and acute diseases.”
Blue Horizon Stem Cells is currently offering adipose stem cell derived treatment for joint diseases at Malacky Hospital in Slovakia. “We have treated more then 10 patients so far, all with outstanding results. Stem cells are a great option when the patient is not a good candidate for traditional forms of treatment, such as invasive surgery or other treatment modalities,”